198 related articles for article (PubMed ID: 21677312)
1. Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia.
Eapen M; Le Rademacher J; Antin JH; Champlin RE; Carreras J; Fay J; Passweg JR; Tolar J; Horowitz MM; Marsh JC; Deeg HJ
Blood; 2011 Sep; 118(9):2618-21. PubMed ID: 21677312
[TBL] [Abstract][Full Text] [Related]
2. Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia.
Chu R; Brazauskas R; Kan F; Bashey A; Bredeson C; Camitta B; Chiang KY; Frangoul H; Gale RP; Gee A; George B; Goldman FD; Gross TG; Gupta V; Hale GA; Isola L; Ispizua AU; Lazarus H; Marsh J; Russell J; Sabloff M; Waller EK; Eapen M
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1018-24. PubMed ID: 21034842
[TBL] [Abstract][Full Text] [Related]
3. Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient.
Maury S; Balère-Appert ML; Chir Z; Boiron JM; Galambrun C; Yakouben K; Bordigoni P; Marie-Cardine A; Milpied N; Kanold J; Maillard N; Socié G;
Haematologica; 2007 May; 92(5):589-96. PubMed ID: 17488681
[TBL] [Abstract][Full Text] [Related]
4. Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia.
Kennedy-Nasser AA; Leung KS; Mahajan A; Weiss HL; Arce JA; Gottschalk S; Carrum G; Khan SP; Heslop HE; Brenner MK; Bollard CM; Krance RA
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1277-84. PubMed ID: 17162209
[TBL] [Abstract][Full Text] [Related]
5. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT.
Dufour C; Veys P; Carraro E; Bhatnagar N; Pillon M; Wynn R; Gibson B; Vora AJ; Steward CG; Ewins AM; Hough RE; de la Fuente J; Velangi M; Amrolia PJ; Skinner R; Bacigalupo A; Risitano AM; Socie G; Peffault de Latour R; Passweg J; Rovo A; Tichelli A; Schrezenmeier H; Hochsmann B; Bader P; van Biezen A; Aljurf MD; Kulasekararaj A; Marsh JC; Samarasinghe S
Br J Haematol; 2015 Nov; 171(4):585-94. PubMed ID: 26223288
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic unrelated bone marrow transplantation from older donors results in worse prognosis in recipients with aplastic anemia.
Arai Y; Kondo T; Yamazaki H; Takenaka K; Sugita J; Kobayashi T; Ozawa Y; Uchida N; Iwato K; Kobayashi N; Takahashi Y; Ishiyama K; Fukuda T; Ichinohe T; Atsuta Y; Mori T; Teshima T;
Haematologica; 2016 May; 101(5):644-52. PubMed ID: 26858357
[TBL] [Abstract][Full Text] [Related]
7. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.
Meisel R; Laws HJ; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Schmitz M; Fischer J; Göbel U; Enczmann J; Dilloo D
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1338-45. PubMed ID: 17950920
[TBL] [Abstract][Full Text] [Related]
8. Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia.
Schrezenmeier H; Passweg JR; Marsh JC; Bacigalupo A; Bredeson CN; Bullorsky E; Camitta BM; Champlin RE; Gale RP; Fuhrer M; Klein JP; Locasciulli A; Oneto R; Schattenberg AV; Socie G; Eapen M
Blood; 2007 Aug; 110(4):1397-400. PubMed ID: 17475907
[TBL] [Abstract][Full Text] [Related]
9. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
[TBL] [Abstract][Full Text] [Related]
10. Second allogeneic stem cell transplant for aplastic anaemia: a retrospective study by the Severe Aplastic Anaemia Working Party of the European Society for Blood and Marrow Transplantation.
Cesaro S; Peffault de Latour R; Tridello G; Pillon M; Carlson K; Fagioli F; Jouet JP; Koh MB; Panizzolo IS; Kyrcz-Krzemien S; Maertens J; Rambaldi A; Strahm B; Blaise D; Maschan A; Marsh J; Dufour C;
Br J Haematol; 2015 Nov; 171(4):606-14. PubMed ID: 26304743
[TBL] [Abstract][Full Text] [Related]
11. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.
Eapen M; Rocha V; Sanz G; Scaradavou A; Zhang MJ; Arcese W; Sirvent A; Champlin RE; Chao N; Gee AP; Isola L; Laughlin MJ; Marks DI; Nabhan S; Ruggeri A; Soiffer R; Horowitz MM; Gluckman E; Wagner JE; ; ;
Lancet Oncol; 2010 Jul; 11(7):653-60. PubMed ID: 20558104
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic stem cell transplantation from related and unrelated donors for aplastic anaemia in adults--a single-centre experience.
Buchholz S; Dammann E; Koenecke Ch; Stadler M; Franzke A; Blasczyk R; Bremer M; Krauter J; Hertenstein B; Ganser A; Eder M
Ann Hematol; 2008 Jul; 87(7):551-6. PubMed ID: 18386010
[TBL] [Abstract][Full Text] [Related]
13. Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia.
Gadalla SM; Wang T; Haagenson M; Spellman SR; Lee SJ; Williams KM; Wong JY; De Vivo I; Savage SA
JAMA; 2015 Feb; 313(6):594-602. PubMed ID: 25668263
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups.
Bacigalupo A; Socié G; Schrezenmeier H; Tichelli A; Locasciulli A; Fuehrer M; Risitano AM; Dufour C; Passweg JR; Oneto R; Aljurf M; Flynn C; Mialou V; Hamladji RM; Marsh JC;
Haematologica; 2012 Aug; 97(8):1142-8. PubMed ID: 22315497
[TBL] [Abstract][Full Text] [Related]
15. Effect of Stem Cell Source and Dose on Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Idiopathic Aplastic Anemia: Data from the Korean Aplastic Anemia Trials.
Kim H; Lee KH; Sohn SK; Kim I; Kim SH; Park Y; Choi JH; Kwak JY; Kim MK; Bae SH; Shin HJ; Won JH; Lee WS; Choi Y;
Acta Haematol; 2020; 143(3):232-243. PubMed ID: 31390612
[TBL] [Abstract][Full Text] [Related]
16. Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study.
Kang HJ; Shin HY; Park JE; Chung NG; Cho B; Kim HK; Kim SY; Lee YH; Lim YT; Yoo KH; Sung KW; Koo HH; Im HJ; Seo JJ; Park SK; Ahn HS;
Biol Blood Marrow Transplant; 2010 Nov; 16(11):1582-8. PubMed ID: 20685256
[TBL] [Abstract][Full Text] [Related]
17. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis.
Barker JN; Davies SM; DeFor T; Ramsay NK; Weisdorf DJ; Wagner JE
Blood; 2001 May; 97(10):2957-61. PubMed ID: 11342417
[TBL] [Abstract][Full Text] [Related]
18. Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic Regions.
Kumar R; Kimura F; Ahn KW; Hu ZH; Kuwatsuka Y; Klein JP; Pasquini M; Miyamura K; Kato K; Yoshimi A; Inamoto Y; Ichinohe T; Wood WA; Wirk B; Seftel M; Rowlings P; Marks DI; Schultz KR; Gupta V; Dedeken L; George B; Cahn JY; Szer J; Lee JW; Ho AY; Fasth A; Hahn T; Khera N; Dalal J; Bonfim C; Aljurf M; Atsuta Y; Saber W
Biol Blood Marrow Transplant; 2016 May; 22(5):932-40. PubMed ID: 26797402
[TBL] [Abstract][Full Text] [Related]
19. Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors: A Report From the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Ravinet A; Cabrespine A; Socié G; Milpied N; Yakoub Agha I; Nguyen S; Michallet M; Menard AL; Maillard N; Mohty M; Suarez F; Huynh A; Marchand T; Deteix C; Cassuto JP; Maury S; Chevallier P; Reman O; Peffault de Latour R; Bay JO
Transplantation; 2016 Aug; 100(8):1732-9. PubMed ID: 26528768
[TBL] [Abstract][Full Text] [Related]
20. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease.
Wagner JE; Rosenthal J; Sweetman R; Shu XO; Davies SM; Ramsay NK; McGlave PB; Sender L; Cairo MS
Blood; 1996 Aug; 88(3):795-802. PubMed ID: 8704232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
